Skip to content

Insider · CIK 0001247340

Thomas L Harrison

director

Files at AGEN (AGENUS INC), ACXP (Acurx Pharmaceuticals, Inc.), AFCG (Advanced Flower Capital Inc.). First filing -, latest -.

In brief

Thomas L Harrison files SEC Form 4 as director at AGEN (AGENUS INC), and also at ACXP (Acurx Pharmaceuticals, Inc.), AFCG (Advanced Flower Capital Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Thomas L Harrison has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 13 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026AGEN
AGENUS INC
AGrant or award
Common Stock
+4,443$6.89$31k51,98811 d ago
Aug 5, 2026AGEN
AGENUS INC
AGrant or award
Stock Optionderivative
+50,000$0.00$050,000Aug 11, 2026
Jul 1, 2026AGEN
AGENUS INC
AGrant or award
Common Stock
+8,547$3.58$31k47,545Jul 7, 2026
Apr 24, 2026AGEN
AGENUS INC
AGrant or award
Stock Optionderivative
+122,500$0.00$0122,500Apr 28, 2026
Apr 20, 2026ACXP
Acurx Pharmaceuticals, Inc.
AGrant or award
Stock Optionderivative
+2,150$0.00$02,150Apr 22, 2026
Apr 1, 2026AGEN
AGENUS INC
AGrant or award
Common Stock
+9,228$3.32$31k38,998Apr 13, 2026
Jan 2, 2026AGEN
AGENUS INC
AGrant or award
Common Stock
+7,691$3.98$31k29,770Jan 5, 2026
Nov 20, 2025AFCG
Advanced Flower Capital Inc.
AGrant or award
Common Stock
+5,474$2.74$15k24,539Nov 24, 2025
Oct 1, 2025AGEN
AGENUS INC
AGrant or award
Common Stock
+5,780$5.01$29k22,079Oct 3, 2025
Jul 1, 2025AGEN
AGENUS INC
AGrant or award
Common Stock
+7,401$3.46$26k16,299Jul 15, 2025
Jun 17, 2025AGEN
AGENUS INC
AGrant or award
Stock Optionderivative
+17,500$0.00$030,000Jul 15, 2025
Apr 1, 2025AGEN
AGENUS INC
AGrant or award
Common Stock
+8,898$2.88$26k8,898Apr 3, 2025
Feb 25, 2025AFCG
Advanced Flower Capital Inc.
AGrant or award
Common Stock
+1,792$8.37$15k19,065Feb 27, 2025

Questions about Thomas L Harrison

Answered from the filings on this page, as of the latest one.

Is Thomas L Harrison buying or selling?

Thomas L Harrison has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Thomas L Harrison's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas L Harrison has 0.

Where does Thomas L Harrison file Form 4?

Thomas L Harrison has filed Form 4 at AGEN (AGENUS INC); ACXP (Acurx Pharmaceuticals, Inc.); AFCG (Advanced Flower Capital Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Thomas L Harrison: insider trades and track record | InsiderTell